Uhmontpellier
Montpellier, 34295, France
NCT Number: NCT04895878
ANCA vasculitis and Sjögren syndrome are two rare diseases, and even more rarely associated. These two conditions have specific organ involvements, and specific follow-up.
The Investigators hypothesise that patients with co-occurrence of these two diseases may have a singular clinical course.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, 34295, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: day 1 (Upon diagnosis)
Severity of Sjögren disease
Time frame: day 1 (Upon diagnosis)
Sjögren extra-glandular complications
Time frame: day 1 (Upon diagnosis)
severity of ANCA vasculitis
University Hospital, Montpellier
Other
Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome : a Case Series and Systematic Review
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06548607
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Bengbu, Anhui, China
View Trial DetailsNCT06420154
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Wenzhou, Zhejiang, China
View Trial DetailsNCT07596680
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07301164
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
View Trial Details